Keywords: CVF; cobra venom factor; nCVF; natural CVF as it occurs in cobra venom; rCVF; recombinantly produced CVF; hCVF; humanized CVF; huC3; human C3; muC3; murine C3; Cobra venom factor; Humanized cobra venom factor; Complement; Complement depletion; Antibody re
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BMD; bone mineral density; CVF; clinical vertebral fracture; DANCE; The Direct Assessment of Nonvertebral Fractures in Community Experience; EFOS; European Forsteo Observational Study; ExFOS; Extended Forsteo Observational Study; JFOS; Japan Fracture Obse
Keywords: PTB; preterm birth; sPTB; spontaneous preterm birth; PTL; preterm labour; CVF; cervicovaginal fluid; FFN; fetal fibronectin; qFFN; quantitative fetal fibronectin; CL; ultrasound cervical length; RANTES; regulated on activation normal T cell expressed and
Keywords: diagnosis; fibrosis; heart failure; mechanisms; myocardium; therapeutics; CITP; collagen Type I telopeptide; CMR; cardiac magnetic resonance; CVF; collagen volume fraction; ECM; extracellular matrix; ECV; extracellular volume; HF; heart failure; MIF; myoc
Keywords: DISI engine; Injector fouling; Mixture preparation; Combustion; Emissions; ASOI; after start of injection; ATDC; after top dead centre; BTDC; before top dead centre; CAD; crank angle degree; CNF; cumulative number fraction; COV; coefficient of variation;
Keywords: ALP; alkaline phosphatase; AP; alternative pathway; BMP; bone morphogenetic protein; CVF; cobra venom factor; GAGs; glycosaminoglycans; IL; interleukine; M-CSF; macrophage colony-stimulating factor; PGs; proteoglycans; RANKL; receptor activator of nuclear
Keywords: AMI; Acute myocardial infarction; C1-inh; C1-inhibitor; C1s-inh; C1s-inhibitor; C4BP; C4b-binding protein; CK(-MB); creatine kinase (-MB); CPN; carboxypeptidase-N; CR1; complement receptor 1; CVF; cobra venom factor; DDA; disodium disuccinate astaxanthin;
Keywords: biomarker; collagen; endomyocardial biopsy; fibrosis; heart failure; CIVF; myocardial collagen type I volume fraction; CIIIVF; myocardial collagen type III volume fraction; CVF; collagen volume fraction; DCM; dilated cardiomyopathy; HF; heart failure; HHD
Keywords: API; Active pharmaceutical ingredients; AV; Aerobic vaginitis; BV; Bacterial vaginosis; CFU; Colony forming units; CRL; Centro de Referencia para Lactobacilos Culture Collection; CVF; Cervicovaginal fluid; EFSA; European Food Safety Authority; FGM; Food G
Keywords: CPN; carboxypeptidase N; CVF; cobra venom factor; EAE; experimental autoimmune encephalomyelitis; MOG; myelin oligodendrocyte glycoprotein; Carboxypeptidase; Demyelinating disease; Kinins; MS/EAE;
Keywords: BLM; bleomycin; NS; normal saline; IS; inflammation score; CVF; collagen volume fraction; Hyp; hydroxyproline; FSC; forward-scattered light; SSC; side-scattered light; AMÏ; alveolar macrophage; IMÏ; interstitial macrophage; Pulmonary fibrosis; Monocyte
Keywords: CVF; cobra venom factor; rCVF; recombinant CVF; hCVF; humanized CVF; MAC; membrane attack complex; PNH; paroxysmal nocturnal hemoglobinuria; MI/RI; myocardial ischemia reperfusion injury; GI/RI; gastrointestinal ischemia reperfusion injury; AMD; age-relat
Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice
Keywords: Naringenin; Diabetes; Cardiac hypertrophy; PPARs; EETs; CYP2J3; AA; arachidonic acid; ANF; atrial natriuretic factor; BW; body weight; CVF; collagen volume fraction; CYP450; cytochrome P450; DCM; diabetic cardiomyopathy; DHM; diabetic cardiac hypertrophy
Quantitative sodium MR imaging: A review of its evolving role in medicine
Keywords: AD; Alzheimer's disease; ATP; adenosine triphosphate; Clâ; chloride ion; CSC; cartilage sodium concentration; CSF; cerebrospinal fluid; CVF; cell volume fraction; DCE; dynamic contrast enhancement; DSC; dynamic susceptibility contrast; ECM; extracellula
Astragalosideâ
£ against cardiac fibrosis by inhibiting TRPM7 channel
Keywords: TRPM7; ASG-â
£; Cardiac fibrosis; Hypoxia; ASG-â
£; astragalosideâ
£; ISO; isoproterenol; ANOVA; analysis of variance; α-SMA; α-smooth muscle actin; CVF; collagen volume fraction; CF; cardiac fibrosis; Col-1; collagen â
; DMEM; dulbecco's modified eagl
1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway
Keywords: 1,25D3; 1,25-dihydroxyvitamin D3; VDR; vitamin D receptor; 25(OH)D; 25-dihydroxyvitamin D; DCM; diabetic cardiomyopathy; CQ; chloroquine; STZ; streptozotocin; lenti-shVDR; lentiviral vectors expressing a short hairpin RNA against VDR; TSC; tuberous sclero
Eculizumab epitope on complement C5: Progress towards a better understanding of the mechanism of action
Keywords: aHUS; atypical hemolytic and uremic syndrome; C5; complement protein C5; CDR; complementarity determining region; CVF; cobra venom factor; DMSO; dimethylsulfoxyde; ECZ; eculizumab; Fab; fragment antigen binding; Fv; fragment variable; mAb; monoclonal anti
Reconstitute the damaged heart via the dual reparative roles of pericardial adipose-derived flk-1+ stem cells
Keywords: pADSC; pericardial adipose-derived stromal cells; flk-1; fetal liver kinase 1; cTnT; cardiac troponin T; vWF; von Willebrand factor; CVF; collagen volume fraction; TnnT2; troponin T type 2 (cardiac); nkx2.5; homeobox protein Nkx-2.5; MEF-2c; myocyte-speci
Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling
Keywords: collagen; ECV; magnetic resonance imaging; mortality; myocardial fibrosis; AS; aortic stenosis; CMR; cardiac magnetic resonance; CVF; collagen volume fraction; ECM; extracellular matrix; ECV; extracellular volume fraction; Hct; hematocrit; HHF; hospitaliz
Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure
Keywords: biomarker; cardiovascular death; heart failure of hypertensive etiology; myocardial fibrosis; CCL; collagen cross-linking; CI; confidence interval; CITP; C-terminal telopeptide of collagen type I; CVF; collagen volume fraction; DM; diabetes mellitus; HF;
Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model
Keywords: cardiac imaging techniques; cardiomyopathy; dual-energy scanned projection; magnetic resonance imaging; mapping; radiography; CMR; cardiac magnetic resonance; CT; computed tomography; CVF; collagen volume fraction; DCM; dilated cardiomyopathy; ECV; extrac
Enhanced recognition of plasma proteins in a non-native state by complement C3b. A possible clearance mechanism for damaged proteins in blood
Keywords: Alternative pathway activation; Complement C3; Extracellular chaperone; Plasma proteins; Denatured proteins; Inflammation; α1PI; alpha 1 proteinase inhibitor; CVF; cobra venom factor; DBP; vitamin D binding protein; HAGG; heat-aggregated human IgG; HSA;
Irreversible Triggers for Hypertrophic Cardiomyopathy Are Established in the Early Postnatal Period
Keywords: genetics; mouse models; CVF; collagen volume fraction; DCM; dilated cardiomyopathy; HCM; hypertrophic cardiomyopathy; LV; left ventricular; LVDD; left ventricular end-diastolic diameter; LVFS; left ventricular fractional shortening; LVH; left ventricular
AIM2 co-immunization favors specific multifunctional CD8+ T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis
Keywords: CVB3; coxsackievirus B3; DCM; dilated cardiomyopathy; AIM2; absent in melanoma 2; TCID50; tissue culture infective dose 50%; LVEF; left ventricular ejection fraction; LVFS; left ventricular fractional shortening; LVEDd; left ventricular end-diastolic dime
Increased Serpin A5 levels in the cervicovaginal fluid of HIV-1 exposed seronegatives suggest that a subtle balance between serine proteases and their inhibitors may determine susceptibility to HIV-1 infection
Keywords: CAN; acetonitrile; ARV; antiretroviral; BCA; bicinchoninic acid assay; BV; bacterial vaginosis; CI; confidence interval; CVF; cervicovaginal fluid; FA; formic acid; FC; fold change; HESNs; HIV-1 exposed seronegative individuals; HIV; human immunodeficienc
Glucocorticoid ameliorates early cardiac dysfunction after coronary microembolization and suppresses TGF-β1/Smad3 and CTGF expression
Keywords: CME; Coronary Microembolization; CTGF; Connective Tissue Growth Factor; CVF; Collagen Volume Fraction; FS; Fractional Shortening; LVEDV; Left Ventricular End-Diastolic Volume; LVEF; Left Ventricular Ejection Fraction; LVESV; Left Ventricular End-Systolic
A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements
Keywords: ADP; adenosine diphosphate; ATII; antithrombin; CH50; complement hemolytic activity 50; CVF; cobra venom factor; HAR; hyperacute rejection; HUVEC; human umbilical vein endothelial cell; HR; heart rate; IgM; immunoglobulin M; LVDP; left ventricular develop
The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response
Keywords: APC; Antigen presenting cell; B6; C57BL/6; C1qRP; C1q receptor P; C3aR; C3a receptor; C5aR; C5a receptor; CR2; Complement receptor 2; CNS; Central nervous system; CVF; Cobra venom factor; DAF; Decay-accelerating factor; EAE; Experimental autoimmune enceph
Actualités dans le traitement étiologique de la sclérose latérale amyotrophique
Keywords: sclérose latérale amyotrophique; neurologie; motoneurone; traitement; survie; amyotrophic lateral sclerosis; neurology; motoneuron; treatment; survival; AALSRS; appel ALS rating scale; ALSFRS; amyotrophic lateral sclerosis functional rating scale; AMM;
Changes in plasma membrane phospholipids inhibit antibody-mediated lysis
Keywords: Ab + C; antibody + complement; AB; l-2-amino-butanol; AP; 3-aminopropanol; C; choline; CVF; cobra venom factor; DME; dimethylethanolamine; E; ethanolamine; MME; monomethylethanolamine; Antibody; Complement; Cytolysis; Phospholipids;
Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization
Keywords: NHS; normal human serum; C4BP; C4b-binding protein; MRSA; methicillin-resistant Staphylococcus aureus; GVBS; gelatin veronal buffered saline; CVF; cobra venom factor; Staphylococcus aureus; Complement; C4b-binding protein; Classical pathway; C3-convertase
Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3
Keywords: mAb; monoclonal antibody; CVF; cobra venom factor; HAG; heat aggregated human IgG; IAP; immunoaffinity purification; ICS; immune-complex surface; PPD; purified protein derivate; Complement; C3c; Monoclonal antibody; ELISA;
An experimental model for studying the biomechanics of embryonic tendon: Evidence that the development of mechanical properties depends on the actinomyosin machinery
Keywords: CVF; cell volume fraction, the fraction of the construct occupied by cells; ECM; extracellular matrix; ECMT; embryonic chick metatarsal tendon; EM; electron microscopy; FACS; fluorescence activated cell sorting; FVF; fibril volume fraction, the fraction o
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion
Keywords: Complement; C3; Cobra venom factor; CVF; Convertase; Protein humanization; Therapeutic complement depletion
Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production
Keywords: EAE; Mouse model; Transient decomplementation; CVF; MOG-specific T-cells; Autoantibody production;
Explorations fonctionnelles respiratoires du grand enfant ou de l'adulte atteint de mucoviscidose
Keywords: BO; bronchiolite oblitérante; BOS; syndrome de bronchiolite oblitérante; CPT; capacité pulmonaire totale; CRF; capacité résiduelle fonctionnelle; CVF; capacité vitale forcée; CVL; capacité vitale lente; DEM; débit expiratoire moyen; VEMS; volume
Evaluation de la fonction respiratoire chez le nourrisson atteint de mucoviscidose
Keywords: Cd; compliance dynamique; CRF; capacité résiduelle fonctionnelle; CRFHe; capacité résiduelle fonctionnelle mesurée; par la technique de dilution de l'hélium; CRFN2; capacité résiduelle fonctionnelle mesurée; par la méthode de rinçage à l'a
Complement Depletion Enhances Pulmonary Inflammatory Response After Liver Injury
Keywords: Cryoablation; acute lung injury; complement; C3; CVF;
Facteurs influençant les variables ventilatoires des Tunisiennes âgées de 45 ans et plus
Keywords: Pléthysmographie; Poumon; Femme; Vieillissement; Parité; Plethysmograpy; Lung; Women; Aging; Parity; ATS; American Thoracic Society; B; Coefficient de régression non standardisé; BPCO; Broncho-Pneumopathie Chronique Obstructive; C; Classe; CDV; Courbe
Investigation of the mechanisms of anti-complement activity in Ixodes ricinus ticks
Keywords: SGE; salivary gland extract; CVF; cobra venom factor; GVB; gelatin-veronal buffered saline; EGTA; ethyleneglycoltetra-acetic acid; REAP; rabbit erythrocyte alternative pathway activation assay; Complement; Ticks; Ixodes ricinus; Alternative pathway of com
Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement
Keywords: ADAM; A disintegrin and metalloproteinase family; CFA; cobra factor acidic; CFB; cobra factor basic; CVF; cobra venom factor; EA; sheep erythrocytes sensitized with rabbit IgG; H-CoF; high molecular weight cobra factor; HPLC; high performance liquid chrom